Aya Miyoshi

746 total citations
27 papers, 610 citations indexed

About

Aya Miyoshi is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Nutrition and Dietetics. According to data from OpenAlex, Aya Miyoshi has authored 27 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Nutrition and Dietetics. Recurrent topics in Aya Miyoshi's work include Cardiac Arrhythmias and Treatments (4 papers), Metabolism and Genetic Disorders (3 papers) and melanin and skin pigmentation (3 papers). Aya Miyoshi is often cited by papers focused on Cardiac Arrhythmias and Treatments (4 papers), Metabolism and Genetic Disorders (3 papers) and melanin and skin pigmentation (3 papers). Aya Miyoshi collaborates with scholars based in Japan, China and United States. Aya Miyoshi's co-authors include S. Kashimura, Isao Yuasa, Kimihiko Matsusue, Frank J. Gonzalez, Kazuo Umetsu, Shigeru Yamano, Yuji Ishii, Kazuta Oguri, Motoki Osawa and Kyung Sook Park and has published in prestigious journals such as Molecular Pharmacology, Drug Metabolism and Disposition and Molecular and Cellular Endocrinology.

In The Last Decade

Aya Miyoshi

27 papers receiving 589 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aya Miyoshi Japan 15 235 152 109 78 77 27 610
Jagdish N. Sharma Kuwait 16 136 0.6× 142 0.9× 30 0.3× 8 0.1× 31 0.4× 35 689
C. E. Watson United States 6 222 0.9× 33 0.2× 20 0.2× 66 0.8× 68 0.9× 10 827
Hongfang Liu China 12 252 1.1× 31 0.2× 16 0.1× 81 1.0× 26 0.3× 26 443
J. N. Sharma Malaysia 15 175 0.7× 130 0.9× 30 0.3× 10 0.1× 22 0.3× 50 665
Jason J. Yuen United States 12 399 1.7× 28 0.2× 41 0.4× 40 0.5× 59 0.8× 13 685
M. Perenna Rogers United Kingdom 14 311 1.3× 110 0.7× 87 0.8× 25 0.3× 27 0.4× 29 607
Zhengbo Duanmu United States 12 132 0.6× 24 0.2× 78 0.7× 10 0.1× 40 0.5× 18 423
Pil-Hoon Park South Korea 12 197 0.8× 40 0.3× 26 0.2× 16 0.2× 19 0.2× 13 575
B. Werner Sweden 11 362 1.5× 28 0.2× 54 0.5× 35 0.4× 155 2.0× 26 715
Engin M. Gözükara United States 14 322 1.4× 12 0.1× 33 0.3× 47 0.6× 24 0.3× 21 585

Countries citing papers authored by Aya Miyoshi

Since Specialization
Citations

This map shows the geographic impact of Aya Miyoshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aya Miyoshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aya Miyoshi more than expected).

Fields of papers citing papers by Aya Miyoshi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aya Miyoshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aya Miyoshi. The network helps show where Aya Miyoshi may publish in the future.

Co-authorship network of co-authors of Aya Miyoshi

This figure shows the co-authorship network connecting the top 25 collaborators of Aya Miyoshi. A scholar is included among the top collaborators of Aya Miyoshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aya Miyoshi. Aya Miyoshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uneno, Yu, Maki Iwai, Naoto Morikawa, et al.. (2022). Development of a national health policy logic model to accelerate the integration of oncology and palliative care: a nationwide Delphi survey in Japan. International Journal of Clinical Oncology. 27(9). 1529–1542. 1 indexed citations
2.
Inden, Yasuya, Masayuki Shimano, Satoshi Yanagisawa, et al.. (2015). Feasibility and Safety of Uninterrupted Dabigatran Therapy in Patients Undergoing Ablation for Atrial Fibrillation. Internal Medicine. 54(10). 1167–1173. 25 indexed citations
3.
Inden, Yasuya, Masayuki Shimano, Satoshi Yanagisawa, et al.. (2014). Efficacy and Safety of Apixaban in the Patients Undergoing the Ablation of Atrial Fibrillation. Pacing and Clinical Electrophysiology. 38(2). 155–163. 40 indexed citations
4.
Yanagisawa, Satoshi, Yasuya Inden, Masayuki Shimano, et al.. (2014). Clinical Characteristics and Predictors of Super‐Response to Cardiac Resynchronization Therapy: A Combination of Predictive Factors. Pacing and Clinical Electrophysiology. 37(11). 1553–1564. 10 indexed citations
5.
Yanagisawa, Satoshi, Yasuya Inden, Masayuki Shimano, et al.. (2013). Clinical Outcome of Implantable Cardioverter Defibrillators With Recalled and Non-Recalled Leads in Japanese Patients. Circulation Journal. 78(2). 353–359. 3 indexed citations
6.
Yuasa, Isao, K. Umetsu, Shinji Harihara, et al.. (2007). Distribution of Two Asian-Related Coding SNPs in the MC1R and OCA2 Genes. Biochemical Genetics. 45(7-8). 535–542. 26 indexed citations
7.
Kitano, Takashi, et al.. (2007). Allele frequencies of a SNP and a 27-bp deletion that are the determinant of earwax type in the ABCC11 gene. Legal Medicine. 10(2). 113–114. 3 indexed citations
8.
Yuasa, Isao, Kazuo Umetsu, Shinji Harihara, et al.. (2007). OCA2*481Thr, a hypofunctional allele in pigmentation, is characteristic of northeastern Asian populations. Journal of Human Genetics. 52(8). 690–693. 24 indexed citations
9.
Yuasa, Isao, K. Umetsu, Shinji Harihara, et al.. (2006). Distribution of the F374 Allele of the SLC45A2 (MATP) Gene and Founder‐Haplotype Analysis. Annals of Human Genetics. 70(6). 802–811. 29 indexed citations
10.
Matsusue, Kimihiko, Aya Miyoshi, Shigeru Yamano, & Frank J. Gonzalez. (2006). Ligand-activated PPARβ efficiently represses the induction of LXR-dependent promoter activity through competition with RXR. Molecular and Cellular Endocrinology. 256(1-2). 23–33. 48 indexed citations
12.
Kashimura, S., et al.. (2005). Successful DNA Typing of Urine Stains Using a DNA Purification Kit Following Dialfiltration. Journal of Forensic Sciences. 50(4). JFS2004484–5. 15 indexed citations
13.
Umetsu, Kazuo, Masashi Tanaka, Isao Yuasa, et al.. (2004). Multiplex amplified product‐length polymorphism analysis of 36 mitochondrial single‐nucleotide polymorphisms for haplogrouping of East Asian populations. Electrophoresis. 26(1). 91–98. 68 indexed citations
15.
Ishii, Yuji, Aya Miyoshi, Minoru Tsuda, et al.. (2001). Simultaneous Expression of Guinea Pig UDP-Glucuronosyltransferase 2B21 and 2B22 in COS-7 Cells enhances UDP-Glucuronosyltransferase 2B21-Catalyzed Morphine-6-Glucuronide Formation. Molecular Pharmacology. 60(5). 1040–1048. 64 indexed citations
16.
Ishii, Yuji, Aya Miyoshi, Minoru Tsuda, et al.. (2001). Simultaneous Expression of Guinea Pig UDP-Glucuronosyltransferase 2B21 and 2B22 in COS-7 Cells enhances UDP-Glucuronosyltransferase 2B21-Catalyzed Morphine-6-Glucuronide Formation. Molecular Pharmacology. 60(5). 1040–1048. 21 indexed citations
17.
Umetsu, Kazuo, Masashi Tanaka, Isao Yuasa, et al.. (2001). Multiplex amplified product-length polymorphism analysis for rapid detection of human mitochondrial DNA variations. Electrophoresis. 22(16). 3533–3538. 34 indexed citations
18.
Liu, Junting, Kenji Hara, S. Kashimura, et al.. (2000). Headspace solid-phase microextraction and gas chromatographic–mass spectrometric screening for volatile hydrocarbons in blood. Journal of Chromatography B Biomedical Sciences and Applications. 748(2). 401–406. 19 indexed citations
19.
Miyoshi, Aya. (1997). Impairment of Endothelial Function in Salt-Sensitive Hypertension in Humans. American Journal of Hypertension. 10(10). 1083–1090. 71 indexed citations
20.
Miyoshi, Aya, et al.. (1997). [Recurrent hypertensive intracerebral hemorrhage: characteristics and risk factors].. PubMed. 25(11). 993–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026